Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab

Affiliations

• ¹ Department of Nephrology and Medical Intensive Care, Charite Universitatsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany lennard.ostendorf@charite.de.
• ² Deutsches Rheuma-Forschungszentrum (DRFZ), an Institute of the Leibniz Association, Berlin, Germany.
• ³ BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
• ⁴ Department of Nephrology and Medical Intensive Care, Charite Universitatsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
• ⁵ Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart Institute, Berlin, Germany.
• ⁶ Department of Emergency and Acute Medicine, Campus Mitte and Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
• ⁷ Department of Rheumatology and Clinical Immunology, Campus Mitte and Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.